-
Aberdeen Israel Fund, Inc. (NYSE AMEX: ISL)
- (EDT)
- » Closed-End Fund Center
Daily Data
At close May 17, 2012
| NAV | $14.29 |
| Price | $12.70 |
| Premium/(Discount) | -11.13% |
NAV and prices are provided by Morningstar. This information is unaudited and neither Aberdeen Asset Management PLC, its wholly owned subsidiaries, the Funds, nor any other person guarantees their accuracy.
Downloads
Quick Links
Request Information
If you require further information on any of our Closed-End Funds:
Aberdeen Israel Fund, Inc. (NYSE AMEX: ISL)
Investment Objective
The Fund seeks long-term capital appreciation by investing primarily in equity securities of Israeli companies.
Fund Manager Interview with Andy Brown
Andy Brown, senior investment manager on Aberdeen’s global emerging markets team, discusses current stock picking opportunities, especially within the tech sector, the hallmark of Israel’s vibrant economy.
Download fund manager interview
Fund Update Webcast
Andy Brown, Investment Manager for Aberdeen Global Emerging Market Equities, discusses Israel’s strong economic fundamentals and growth potential, which is underpinned by a young and growing population. Learn more about the fund’s recent results and portfolio positioning.
Listen to webcastInvestment Policies
It is the policy of the Fund to invest its assets in Israeli equity securities. For these purposes, “Israeli securities” includes common and preferred stock, warrants, options and debt securities organized under the laws of Israel.
The information contained above provides only a brief summary description of the Fund's investment objective and investment policies.
Fund Managers’ Monthly Report
April 2012
- Israel’s benchmark TA-100 Index rose in March, helped by positive U.S. economic data and China’s renewed pledge to support Europe.
- The central bank kept interest rates unchanged and raised its economic growth forecast for the year to 3.1%. Unemployment rose to 6.5% in February.
- In politics, Israel deepened its economic ties with China via a US$300 million sale of its water technology.
- During the month, we pared our positions in Check Point Software Technologies, over-the-counter drug-maker Perrigo, and Mizrahi Bank. With the proceeds, we added to our holdings in Teva Pharmaceutical and Bezeq Telecommunication.
To receive this, or any other monthly fund factsheet directly in your inbox, sign up for our email services.
.........